1
|
Shah HS, Serrano PA, Phillips Ii G. Adaptation and Reach of a Pre-Exposure Prophylaxis Social Marketing Campaign for Latino, Latina, and Latinx Populations: Development Study. JMIR Form Res 2024; 8:e52842. [PMID: 39018099 PMCID: PMC11292145 DOI: 10.2196/52842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2023] [Revised: 03/16/2024] [Accepted: 04/24/2024] [Indexed: 07/18/2024] Open
Abstract
BACKGROUND Latino, Latina, and Latinx (Latino/a/x) individuals remain disproportionately impacted by HIV, particularly sexual minority men and transgender women. Pre-exposure prophylaxis (PrEP) is an effective means of biomedical HIV prevention, but awareness and uptake remain low among marginalized Latino/a/x populations. Social marketing campaigns have demonstrated promise in promoting PrEP in other populations but are poorly studied in Latino/a/x sexual minority men and transgender women. OBJECTIVE This study aims to (1) adapt and pilot a PrEP social marketing campaign tailored to Latino/a/x populations with a focus on sexual minority men and transgender women through community-based participatory research (CBPR) and (2) evaluate the reach and ad performance of the adapted PrEP social marketing campaign. METHODS We used the ADAPT-ITT (assessment, decision, adaptation, production, topical experts-integration, training, and testing) framework for adapting evidence-based interventions for new settings or populations. This paper presents how each phase of the ADAPT-ITT framework was applied via CBPR to create the PrEPárate ("Be PrEPared") campaign. Key community engagement strategies included shared ownership with community partners, focus groups to guide content, crowdsourcing to name the campaign, design by local Latino/a/x artists, and featuring local influencers as the faces of PrEPárate. We evaluated campaign reach and advertisement performance using social media platform metrics (paid and organic reach, impressions, unique clicks, and click-through rates [CTR]) and website use statistics from Google Analytics. RESULTS The PrEPárate campaign ran in Cook County, Illinois, from April to September 2022. The campaign reached over 118,750 people on social media (55,750 on Facebook and Instagram [Meta Platforms Inc] and 63,000 on TikTok [ByteDance Ltd]). The Meta ads performed over the industry benchmark with ads featuring local transgender women (2% CTR) and cisgender sexual minority men (1.4% CTR). Of the different Grindr (Grindr Inc) ad formats piloted, the interstitial Grindr ads were the highest performing (1183/55,479, 2.13% CTR). YouTube (Google) ads were low performing at 0.11% (153/138,337) CTR and were stopped prematurely, given limits on sexual education-related content. In the first year, there were 5006 visitors to the website. CONCLUSIONS Adaptation of an existing evidence-based intervention served as an effective method for developing a PrEP social marketing campaign for Latino/a/x audiences. CBPR and strong community partnerships were essential to tailor materials and provide avenues to systematically address barriers to PrEP access. Social marketing is a promising strategy to promote PrEP among underserved Latino/a/x populations.
Collapse
Affiliation(s)
- Harita S Shah
- Department of Medicine, University of Chicago, Chicago, IL, United States
| | - Pedro Alonso Serrano
- Department of Medical Social Sciences, Northwestern University, Chicago, IL, United States
- Department of Preventive Medicine, Northwestern University, Chicago, IL, United States
| | - Gregory Phillips Ii
- Department of Medical Social Sciences, Northwestern University, Chicago, IL, United States
- Department of Preventive Medicine, Northwestern University, Chicago, IL, United States
| |
Collapse
|
2
|
Tieosapjaroen W, Zhang Y, Fairley CK, Zhang L, Chow EPF, Phillips TR, Schmidt HM, Bavinton BR, O'Donnell D, Mao L, Grulich A, Ong JJ. Improving access to oral pre-exposure prophylaxis for HIV among international migrant populations. Lancet Public Health 2023; 8:e651-e658. [PMID: 37421969 DOI: 10.1016/s2468-2667(23)00105-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2023] [Revised: 05/09/2023] [Accepted: 05/15/2023] [Indexed: 07/10/2023]
Abstract
Pre-exposure prophylaxis (PrEP) is recommended for people susceptible to HIV acquisition, and the scale-up of PrEP programmes has contributed to new HIV case reductions at a population level. However, international migrants continue to be disproportionately affected by HIV. Understanding barriers and facilitators to PrEP implementation among international migrants can optimise PrEP use among this population and ultimately reduce HIV incidence worldwide. We reviewed the evidence regarding factors influencing PrEP implementation among international migrants; 19 studies were included. The barriers and facilitators at the individual level were related to knowledge and risk perception of HIV. Cost, provider discriminations, and health system navigation influenced PrEP use at the service level. Positive or negative perception towards LGBT+ identities, HIV, and PrEP users affected PrEP use at the societal level. Most existing PrEP campaigns do not target international migrants; therefore, culturally tailored approaches for people from different backgrounds are warranted. Potentially migration-related and HIV-related discriminatory policies must be reviewed to increase access to HIV prevention services to end HIV transmission at a population level.
Collapse
Affiliation(s)
- Warittha Tieosapjaroen
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
| | - Ying Zhang
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
| | - Christopher K Fairley
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
| | - Lei Zhang
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
| | - Eric P F Chow
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia
| | - Tiffany R Phillips
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia
| | - Heather-Marie Schmidt
- UNAIDS Regional Office for Asia and the Pacific, Bangkok, Thailand; Global HIV, Hepatitis and STIs Programme, World Health Organization, Geneva, Switzerland
| | | | - Darryl O'Donnell
- Kirby Institute, University of New South Wales, Sydney, NSW, Australia; Australian Federation of AIDS Organisations, Sydney, NSW, Australia
| | - Limin Mao
- Centre for Social Research in Health, UNSW Sydney, NSW, Australia
| | - Andrew Grulich
- Kirby Institute, University of New South Wales, Sydney, NSW, Australia
| | - Jason J Ong
- Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
| |
Collapse
|
3
|
Tross S, Spector AY, Ertl MM, Berg H, Turrigiano E, Hoffman S. A Qualitative Study of Barriers and Facilitators of PrEP Uptake Among Women in Substance Use Treatment and Syringe Service Programs. AIDS Behav 2023; 27:1162-1172. [PMID: 36318430 PMCID: PMC10796210 DOI: 10.1007/s10461-022-03853-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/02/2022] [Indexed: 11/05/2022]
Abstract
PrEP is an HIV prevention option that could benefit substance-involved women, a high-risk population with low PrEP uptake. Little is known about their interest in PrEP. This qualitative study used in-depth interviews to examine PrEP willingness, barriers, and facilitators among 16 women in outpatient psychosocial substance use treatment, methadone, and/or harm reduction/syringe programs in NYC. All expressed willingness to use PrEP, but only during periods of perceived risk. Women perceived themselves to be at high risk for HIV when engaging in active substance use and/or transactional sex. They perceived themselves to be at low risk and therefore unmotivated to take PrEP when abstinent from these activities. Paradoxically, a major barrier to using PrEP was anticipated interference from substance use and transactional sex, the very same activities that create a perception of risk. Facilitators of PrEP use included perceptions of it as effortless (as opposed to barrier methods during sex) and effective, safe, and accessible. Other barriers included fear of stigma and doubts about adhering daily. Recommendations for best PrEP implementation practices for substance-involved women included tailored and venue-specific PrEP information and messaging, PrEP discussion with trusted medical providers, and on-site PrEP prescription in substance use treatment and harm reduction programs.
Collapse
Affiliation(s)
- Susan Tross
- HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University Irving Medical Center, 722 West 168th Street, 10032, New York, NY, USA.
| | - Anya Y Spector
- Department of Human Services, Stella and Charles Guttman Community College, City University of New York, New York, NY, USA
| | - Melissa M Ertl
- HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University Irving Medical Center, 722 West 168th Street, 10032, New York, NY, USA
| | - Hayley Berg
- Albert Einstein College of Medicine, Bronx, NY, USA
| | | | - Susie Hoffman
- HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, Columbia University Irving Medical Center, 722 West 168th Street, 10032, New York, NY, USA
- Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA
| |
Collapse
|
4
|
Grieb SMD, Velez M, Corty EW, Saxton RE, Flores-Miller A, Shah HS, Page KR. HIV-related stigma among Spanish-speaking Latinos in an emerging immigrant city following the Solo Se Vive Una Vez social marketing campaign. PLoS One 2022; 17:e0274888. [PMID: 36201494 PMCID: PMC9536543 DOI: 10.1371/journal.pone.0274888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2021] [Accepted: 09/06/2022] [Indexed: 11/05/2022] Open
Abstract
HIV-related stigma exacerbates Latino immigrants' risk of HIV infection and delayed care. Following the implementation of the social marketing campaign Sólo Se Vive Una Vez (You Only Live Once) to increase HIV testing that addressed stigmatizing beliefs, we conducted a survey among Latinos in Baltimore, Maryland (N = 357). The aims of this paper are to 1) characterize the sociodemographic characteristics, HIV-related stigma beliefs, and testing behaviors of the survey respondents by campaign exposure, and 2) model the effects of Vive exposure on stigma beliefs and testing behaviors. Comparing post-campaign survey respondents exposed and unexposed to the campaign to survey findings previously obtained and reported before the campaign implementation, respondents to the post-Vive survey continued to hold high levels of stigma beliefs, and compared to the pre-Vive survey sample, were more likely to hold four or more stigmatizing beliefs (from the six survey items). Among the post-Vive survey respondents, those for whom religion was important or very important had an increased odds of 1.6 of holding four or more stigmatizing beliefs. Survey respondents who were exposed to the campaign, however, had an increased odds of 2.25 of reporting ever having been tested for HIV. Our findings demonstrate the importance of the changing social context in addressing stigma within emerging immigrant communities and highlight the critical role of religious leaders in efforts to address HIV-related stigma.
Collapse
Affiliation(s)
- Suzanne M. Dolwick Grieb
- Center for Child and Community Health Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Matthew Velez
- Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America
| | - Edward W. Corty
- Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America
| | - Ronald E. Saxton
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Alejandra Flores-Miller
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Harita S. Shah
- Department of Medicine, University of Chicago, Chicago, Illinois, United States of America
| | - Kathleen R. Page
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| |
Collapse
|
5
|
Tesoriero JM, Yuan Y, Newport R, O'Grady T, Cotroneo R, Stevens L, Grisham T, Seo S, Gonzalez C. Assessing the Impact of a PrEP Aware Week Campaign on PrEP Prescription Fills in NYS. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE 2022; 28:463-468. [PMID: 35867501 PMCID: PMC9983742 DOI: 10.1097/phh.0000000000001554] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
CONTEXT The New York State (NYS) Department of Health AIDS Institute engaged stakeholders across NYS to participate in the state's first "PrEP Aware Week" (PAW). PAW sought to increase the knowledge, interest, and number of PrEP (pre-exposure prophylaxis) prescriptions filled across NYS. PAW activities were designed to be easy to implement, with minimal cost. Stakeholders were provided activities to implement, along with a social media tool kit featuring videos, graphic ads, and sample social media posts in English and Spanish to use as is or modify. PAW included more than 750 distinct events and activities undertaken by more than 250 participating providers. OBJECTIVE To assess the impact of PAW on PrEP prescription filling patterns in NYS. DESIGN An interrupted time-series analysis was conducted to estimate the impact of PAW on overall and new PrEP prescription filling patterns. Separate models were developed by sex (male, female), race and ethnicity (White non-Hispanic, Black non-Hispanic, Hispanic, other, unknown), and region (New York City, rest of NYS). SETTING PAW took place across NYS during the week beginning October 20, 2019. PARTICIPANTS PAW was undertaken by more than 250 health care providers, nonmedical health & human services providers, local and state health department staff, and colleges and universities. MAIN OUTCOME MEASURES The number of overall and new PrEP prescriptions. RESULTS PAW was associated with modest increases (6%-9%) in the number of PrEP prescription fills in NYS. The PAW impact lasted for about 2 months, generated an estimated 2727 additional PrEP prescription fills statewide, and was realized across sex, region, and racial and ethnic subgroups. Increased prescription fills were driven by those previously prescribed PrEP. Increases in new prescriptions were noted among Latinx individuals (21% increase, 55 additional prescriptions) but not overall or across other groups. CONCLUSION NYS's PAW was effective at increasing PrEP prescription refills in NYS.
Collapse
Affiliation(s)
- James M. Tesoriero
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Yingchao Yuan
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Rachel Newport
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Thomas O'Grady
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Richard Cotroneo
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Lyn Stevens
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Thomas Grisham
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Seungjun Seo
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| | - Charles Gonzalez
- Center for Program Development, Implementation, Research and Evaluation (Drs Tesoriero and O'Grady), Office of Sexual Health and Epidemiology (Dr Yuan), Office of the Medical Director (Ms Newport, Mr Cotroneo, and Dr Gonzalez), and Medicaid Policy and Health Care Financing (Messrs Grisham and Seo), New York State Department of Health AIDS Institute, Albany, New York; and Office of the Medical Director, New York State Department of Health AIDS Institute, Syracuse, New York (Ms Stevens)
| |
Collapse
|